New Bill could enhance UK clinical trial regulation
European Pharmaceutical Review
OCTOBER 27, 2023
If achieved, this would boost the UK’s competitiveness as a leading international site for trials. A new sixty-day limit would be implemented for those conducting a trial to respond to Requests for Further Information (RFI) from the MHRA or Research Ethics Committees (RECs).
Let's personalize your content